Morgan Stanley
NMTC icon

Morgan Stanley’s NeuroOne Medical Technologies NMTC Stock Holding History

Morgan Stanley’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.39K Sell
2,016
-2,315
-53% -$11.1K ﹤0.01% 6966
2025
Q4 		$19.7K Buy
4,331
+2,250
+108% +$10.2K ﹤0.01% 6699
2025
Q3 		$11.1K Sell
2,081
-158
-7% -$773 ﹤0.01% 6872
2025
Q2 		$9.11K Buy
2,239
+248
+12% +$916 ﹤0.01% 6880
2025
Q1 		$10.2K Buy
+1,991
New +$12.6K ﹤0.01% 6792
2023
Q1 		– Sell
-450
Closed -$3.24K – 7795
2022
Q4 		$3.24K Buy
+450
New +$4.03K ﹤0.01% 7255

Other funds holding NMTC

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Sio Capital Management New York $694M AUM 79.73% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return